Clin2
NCT07046260Possibly a fitRecruiting

Blood test study for early cancer detection

Cancer

Treatments studied

Part of Cancer clinical trials.

This study is testing a new blood test to help doctors find cancer earlier. If you are 45 or older and have symptoms that might be cancer, or were recently diagnosed with cancer, you may be able to join.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
1,650 people
Ages
45 years and older
Study type
Observational

Who can take part

  • You are 45 years old or older.
  • You have symptoms, signs, or test results that make your doctor think you might have cancer, OR you were diagnosed with cancer within the last 90 days and haven't started treatment.
  • You have never had another cancer (except for a completely removed non-invasive breast cancer or a non-melanoma skin cancer).
  • You do not have a fever over 101.5°F in the last 48 hours.
  • You are not pregnant.
  • You have not had an organ transplant, blood transfusion in the last 120 days, or a stem cell transplant from someone else.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07598747Recruiting
Blood test to detect cancer early using DNA analysis

This study tests whether a new blood test can detect multiple types of cancer early by analyzing DNA fragments in your blood. Researchers are enrolling people recently diagnosed with cancer (before treatment starts) and people without cancer to develop and validate this detection method.

Seoul
NCT05556603Recruiting
Blood test trial to detect pancreatic cancer early

This trial studies whether a blood-based test can help detect pancreatic cancer (or strong signs of it) earlier than usual. The goal is to see how well “liquid biopsy” results match real diagnoses and risk levels.

Shanghai, Shanghai Municipality
NCT05088395Recruiting
Blood tests to track cancer signals after treatment

This study measures “circulating tumor markers,” meaning substances from cancer that can show up in blood, to better understand how cancer is doing after treatment. You may join if you recently received cancer care at a participating center and meet basic study and follow-up requirements.

Paris
NCT06217900Recruiting
Blood test for early detection of multiple cancers (PROFOUND)

This study is testing a new blood test that may help find multiple types of cancer early. It compares blood samples from people with newly diagnosed cancer to those without cancer.

Beijing, Beijing Municipality
NCT06656728Recruiting
Simplifying cancer screening with a new tool

This trial tests a new screening tool that helps doctors find cancer. It involves completing medical exams and questionnaires. The study is for people who have not had cancer in the last 5 years.

Tel Aviv
NCT05227534Recruiting
Test for early cancer signals in people without symptoms

This trial checks whether a blood test can detect early signs of multiple cancers in people who feel well. It may help find cancer earlier, when treatment is more likely to work.

Chengdu, Sichuan

Hear when a new Cancer trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.